Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2 variant 1 pseudogene 9 (UBE2V1P9)

Target
UBE2V1P9
Molecular classification
Other (Pseudogene)
01

Overview

UBE2V1 pseudogene 9 (UBE2V1P9) is a non-functional genomic locus highly homologous to the protein-coding UBE2V1 gene, which belongs to the E2 ubiquitin-conjugating enzyme family[1][5]. Pseudogenes do not encode functional proteins and generally do not participate directly in biological pathways, drug targeting, or disease mechanisms. Multiple pseudogenes for UBE2V1 exist in the human genome, including this member, which is mainly of interest for comparative genomics and evolutionary studies rather than as a biological or therapeutic target[5]. The functional UBE2V1 gene is involved in K63-linked polyubiquitination, protein aggregation, and has proto-oncogenic activity[3][1][5]. However, pseudogenes, including UBE2V1P9, are not direct contributors to these functions. Queries involving UBE2V1P9 as a therapeutic target are incorrect or biologically irrelevant; focus should be on the functional protein if drug- or disease-oriented details are needed. If you require structured or mechanistic data on the active enzyme, refer to “Ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1)”, not the pseudogene.

Other names
ubiquitin conjugating enzyme E2 V1 pseudogene 9ubiquitin-conjugating enzyme E2 variant 1 pseudogene 9ubiquitin-conjugating enzyme E2 variant 2 pseudogene

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2 variant 1 pseudogene 9 (UBE2V1P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 variant 1 pseudogene 9 (UBE2V1P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call